Who do we support?

TDA supports students, staff, faculty and alumni of the University of Zurich (UZH) who have an idea for a future therapy (drug or medical device), diagnostic tool or any innovation that can lead to better patient care. Projects usually already have a patent protecting their idea but this is not mandatory. We support projects with commercial as well as non-commercial goals. 

TDA evaluates all the projects submitted and offers them short-term support if they are in its scope.

Selection for long-term support (including financial support) is done by the Portfolio Committee and is based on the following criteria:

  • Targets an unmet medical need and can have a significant impact
  • Shows an innovative approach
  • Has the potential to advance to clinic or commercialization within 2-4 years